ResearcherHarvard UniversityActive in the last 2 years
Shazia Bano
Matched on ORCID iD 0000-0002-8870-3805; OpenAlex author ID A5049585562. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers
Papers 6
- Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer. Co-author DOI 10.1016/j.jphotobiol.2023.112811↗
- Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jphotobiol.2024.112910↗
- Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer. First author DOI 10.1002/advs.202104594↗
- Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancre… First author DOI 10.1515/nanoph-2021-0304↗
- NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer. Co-author DOI 10.3390/jcm9082390↗
- Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towar… First author DOI 10.1021/acs.nanolett.9b00859↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tayyaba Hasan · 6 shared papers, 2019–2024 · strength 1.01
- Paper Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer. DOI 10.1016/j.jphotobiol.2023.112811↗
- Paper Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic… DOI 10.1016/j.jphotobiol.2024.112910↗
- Paper Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D… DOI 10.1515/nanoph-2021-0304↗
- Girgis Obaid · 4 shared papers, 2019–2024 · strength 0.59
- Paper Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer. DOI 10.1016/j.jphotobiol.2023.112811↗
- Paper NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targe… DOI 10.3390/jcm9082390↗
- Paper Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancrea… DOI 10.1002/advs.202104594↗
- Mari A. Mino-Kenudson · 2 shared papers, 2022–2024 · strength 0.38
- Paper Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer. DOI 10.1016/j.jphotobiol.2023.112811↗
- Paper Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancrea… DOI 10.1002/advs.202104594↗
- Brian William Pogue · 2 shared papers, 2020–2021 · strength 0.28
- Paper Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D… DOI 10.1515/nanoph-2021-0304↗
- Paper NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targe… DOI 10.3390/jcm9082390↗
- Huang‐Chiao Huang · 1 shared paper, 2024 · strength 0.26
- Pushpamali De Silva · 1 shared paper, 2021 · strength 0.16
- Kenneth K. Wang MD · 1 shared paper, 2021 · strength 0.16
- Edward V. Maytin · 1 shared paper, 2021 · strength 0.16
- Anne‐Laure Bulin · 1 shared paper, 2019 · strength 0.09
- Mans Broekgaarden · 1 shared paper, 2019 · strength 0.09
- Srivalleesha Mallidi · 1 shared paper, 2019 · strength 0.09
- Diane M. Simeone · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.